The DOI matches its Crossref record; 363 of the 375 references it cites were found in a registry or an index.
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Abstract
Androgens, acting through the androgen receptor (AR), are responsible for the development of the male phenotype during embryogenesis, the achievement of sexual maturation at puberty, and the maintenance of male reproductive function and behavior in adulthood. In addition, androgens affect a wide variety of nonreproductive tissues. Moreover, aberrant androgen action plays a critical role in multiple pathologies, including prostate cancer and androgen insensitivity syndromes. The formation of a productive AR transcriptional complex requires the functional and structural interaction of the AR with its coregulators. In the last decade, an overwhelming and ever increasing number of proteins have been proposed to possess AR coactivating or corepressing characteristics. Intriguingly, a vast diversity of functions has been ascribed to these proteins, indicating that a multitude of cellular functions and signals converge on the AR to regulate its function. The current review aims to provide an overview of the AR coregulator proteins identified to date and to propose a classification of these AR coregulator proteins according to the function(s) ascribed to them. Taken together, this approach will increase our understanding of the cellular pathways that converge on the AR to ensure an appropriate transcriptional response to androgens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Androgen receptors can be modulated by specific proteins called coregulators [70–72] or mediated via the activation of membrane-bound protein receptors to initiate intracellular signalling pathways [73], which can occur even in the presence of low levels of androgens [74].”
From Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement (2021) · cites this paper as [71]
Citations
Cites
The Role of Chromatin during Transcription
Li, B., Carey, M., & Workman, J. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.015 · Cited by 3,503
MOLECULAR MECHANISMS OF ACTION OF STEROID/THYROID RECEPTOR SUPERFAMILY MEMBERS
Tsai, M., & O’Malley, B. W. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002315 · Cited by 2,887
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily
Oñate, S. A., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1995) · Science · doi:10.1126/science.270.5240.1354 · Cited by 2,398
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
Metzger, E., Wissmann, M., Yin, N., Müller, J. M., Schneider, R., Peters, A. H. F. M., Günther, T., Buettner, R., & Schüle, R. (2005) · Nature · doi:10.1038/nature04020 · Cited by 1,780
Androgen Receptor Defects: Historical, Clinical, and Molecular Perspectives*
Quigley, C. A., Bellis, A. D., Marschke, K. B., Awady, M. K. E., Wilson, E. M., & French, F. S. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-271 · Cited by 1,459
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
Mukhopadhyay, D., & Riezman, H. (2007) · Science · doi:10.1126/science.1127085 · Cited by 1,221
Regulation of Transcription by a Protein Methyltransferase
Chen, D., Ma, H., Hong, H., Koh, S. S., Huang, S., Schurter, B. T., Aswad, D. W., & Stallcup, M. R. (1999) · Science · doi:10.1126/science.284.5423.2174 · Cited by 1,214
Steroid 5α-reductase: two genes/two enzymes
Russell, D. W., & Wilson, J. D. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000325 · Cited by 1,105
Flagged first, then by citations
12 of the 375 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Litvinov, 2003, Is the Achilles’ heel for prostate cancer therapy a gain of function in androgen receptor signaling?, J Clin Endocrinol Metab, 88, 2972, 10.1210/jc.2002-022038 · DOI
Cited by
Sorted by citations
Items 301–400 of 753
Influence of sex on gene expression in human corneal epithelial cells.
Suzuki, T., Richards, S. M., Liu, S., Jensen, R. V., & Sullivan, D. A. (2009) · PubMed Central · Cited by 27
Androgen Regulates Mafb Expression Through its 3′UTR During Mouse Urethral Masculinization
Matsushita, S., Suzuki, K., Ogino, Y., Hino, S., Sato, T., Suyama, M., Μatsumoto, T., Omori, A., Inoue, S., & Yamada, G. (2015) · Endocrinology · doi:10.1210/en.2015-1586 · Cited by 27
Androgen receptor moonlighting in the prostate cancer microenvironment
Cioni, B., Zwart, W. T., & Bergman, A. M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0042 · Cited by 27
Carbajal-García, A., Reyes-García, J., & Montaño, L. M. (2020) · International Journal of Endocrinology · doi:10.1155/2020/8849641 · Cited by 29
Transgelin induces apoptosis of human prostate LNCaP cells through its interaction with p53
Zhang, Z.-W., Yang, Z., Zheng, Y., & Chen, Z.-D. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2009.76 · Cited by 26
Touzón, M. S., Garrido, N. P., Marino, R. M., Ramirez, P., Costanzo, M., Guercio, G., Berensztein, E. B., Rivarola, M. A., & Belgorosky, A. (2018) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.0185 · Cited by 26
Androgen receptor signalling in non-prostatic malignancies: challenges and opportunities
Dotto, G. P., Buckinx, A., Özdemir, B. C., & Simon, C. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00772-w · Cited by 26
Kim, Y. S., Kim, J., Jang, S.-W., & Ko, J. (2014) · Oncogene · doi:10.1038/onc.2013.538 · Cited by 26
Touzón, M. S., Garrido, N. P., Marino, R. M., Ramírez, P., Costanzo, M., Guercio, G., Berensztein, E. B., Rivarola, M. A., & Belgorosky, A. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2018.2018.0185 · Cited by 26
Videira, A., Beckedorff, F., daSilva, L. F., & Verjovski‐Almeida, S. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-020-00691-x · Cited by 26
Wei, J., Yin, L., Li, J., Wang, J., Pu, T., Duan, P., Lin, T., Gao, A. C., & Wu, B. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0198 · Cited by 26
Ban, F., Leblanc, E., Cavga, A. D., Huang, C.-C. F., Flory, M. R., Zhang, F., Chang, M. E. K., Morin, H., Lallous, N., Singh, K., et al. (2021) · Cancers · doi:10.3390/cancers13143488 · Cited by 29
Developing Isoxazole as a Native Photo‐Cross‐Linker for Photoaffinity Labeling and Chemoproteomics
Cheng, K., Qi, J., Ren, X., Zhang, J., Li, H., Xiao, H., Wang, R. Y., Liu, Z., Meng, L., Ma, N., et al. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202209947 · Cited by 27
Pozas, J., Rodríguez, S. Á., Albarrán, V., Burgos, J., Santoni, M., Kopp, R. M., Molina‐Cerrillo, J., & Alonso‐Gordoa, T. (2022) · Cancers · doi:10.3390/cancers14246071 · Cited by 28
GEMIN4 functions as a coregulator of the mineralocorticoid receptor
Yang, J., Fuller, P. J., Morgan, J., Shibata, H., Clyne, C. D., & Young, M. J. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0078 · Cited by 26
Keratin 18 attenuates estrogen receptor α-mediated signaling by sequestering LRP16 in cytoplasm
Meng, Y., Wu, Z., Yin, X., Zhao, Y., Chen, M., Si, Y., Yang, J., Fu, X., & Han, W. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-96 · Cited by 26
New Opportunities for Targeting the Androgen Receptor in Prostate CancerPreprint
Centenera, M. M., Selth, L. A., Ebrahimie, E., Butler, L. M., & Tilley, W. D. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a030478 · Cited by 26
Androgen receptor cofactors: A potential role in understanding prostate cancer
Li, X., Xiong, H., Mou, X., Huang, C., Thomas, E. R., Yu, W., Jiang, Y., & Chen, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116338 · Cited by 26
Effects of resistance training on testosterone metabolism in younger and older men
Ahtiainen, J. P., Nyman, K., Huhtaniemi, I. T., Parviainen, T., Helste, M., Rannikko, A. S., Kraemer, W. J., & Häkkinen, K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.010 · Cited by 25
Song, C.-H., Lee, H. J., Park, E., & Lee, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049026 · Cited by 25
Nuclear Trafficking and Functions of Endocytic Proteins Implicated in Oncogenesis
Borlido, J., Zecchini, V. R., & Mills, I. G. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00922.x · Cited by 25
Luo, M., Li, Y., Guo, H., Lin, S., Chen, J., Ma, Q., Gu, Y., Jiang, Z., & Gui, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226186 · Cited by 25
Cadwallader, A. B., Lim, C. S., Rollins, D. E., & Botrè, F. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.9.594 · Cited by 25
WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer
Leach, D. A., Powell, S. M., & Bevan, C. L. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0319 · Cited by 25
Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target
Yeoh, C. C., Dabab, N., Rigby, E., Chhikara, R., Akaev, I., Gomez, R. S., Fonseca, F. P., Brennan, P. A., & Rahimi, S. (2018) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12741 · Cited by 26
Harada, N., Katsuki, T., Takahashi, Y., Masuda, T., Yoshinaga, M., Adachi, T., Izawa, T., Kuwamura, M., Nakano, Y., Yamaji, R., et al. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25054 · Cited by 25
The crucial role of estrogen/androgen hormones and their receptors in male infertility risk
Rivera-Diaz, P. A., Ortíz, C. P., & Delgado, D. R. (2021) · doi:10.22034/cajmpsi.2021.01.06 · Cited by 24
Chua, T. C., Peng, Y., Akther, J., Young, L., Bao, S., Samaraweera, U., Yan, T. D., & Morris, D. L. (2009) · Pathology & Oncology Research · doi:10.1007/s12253-009-9170-0 · Cited by 24
Androgen receptor antagonists: a patent review (2008 – 2011)
Mohler, M. L., Coss, C. C., Duke, C. B., Patil, S. A., Miller, D. D., & Dalton, J. T. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.682571 · Cited by 25
Takayama, K. (2017) · Endocrine Journal · doi:10.1507/endocrj.ej17-0328 · Cited by 24
Li, C., Yang, B., Pan, P., Ma, Q., Wu, Y., Zhang, Z., Guo, X., Ye, J., & Gui, Y. (2018) · Molecular Reproduction and Development · doi:10.1002/mrd.23058 · Cited by 24
Dissecting the Hormonal Signaling Landscape in Castration-Resistant Prostate Cancer
Fontana, F., & Limonta, P. (2021) · Cells · doi:10.3390/cells10051133 · Cited by 24
Androgens regulate Hedgehog signalling and proliferation in androgen‐dependent prostate cells
Sirab, N., Terry, S., Giton, F., Caradec, J., Chimingqi, M., Moutereau, S., Vacherot, F., TAILLE, A. D. L., Kouyoumdjian, J., & Loric, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.27384 · Cited by 24
Involvement of three glutamine tracts in human androgen receptor transactivation
Harada, N., Mitani, T., Higashimura, Y., Yamaji, R., Okamoto, K., Nakano, Y., & Inui, H. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.10.003 · Cited by 24
Hypoxia enhances ligand-occupied androgen receptor activity
Park, C., Kim, Y., Shim, M., & Lee, Y. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.019 · Cited by 22
RNA-Seq Identifies Key Reproductive Gene Expression Alterations in Response to Cadmium Exposure
Hu, H., Lü, X., Cen, X., Chen, X., Li, F., & Zhong, S. (2014) · BioMed Research International · doi:10.1155/2014/529271 · Cited by 24
Structural and functional association of androgen receptor with telomeres in prostate cancer cells
Zhou, J., Richardson, M., Reddy, V., Menon, M., Barrack, E. R., Reddy, G. P., & Kim, S. (2013) · Aging · doi:10.18632/aging.100524 · Cited by 23
Androgens and the molecular epidemiology of prostate cancer
Chu, L. W., Reichardt, J. K. V., & Hsing, A. W. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3282febcf6 · Cited by 24
Targeting AR Variant–Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities
Magani, F., Peacock, S. O., Rice, M. A., Martinez, M. J., Greene, A. M., Magani, P. S., Lyles, R. D. Z., Weitz, J., & Burnstein, K. L. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0280 · Cited by 25
Howe, C. G., Liu, X., Hall, M. N., Ilievski, V., Caudill, M. A., Malysheva, O., Lomax-Luu, A. M., Parvez, F., Siddique, A. B., Shahriar, H., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0202 · Cited by 24
Heemers, H. V., Schmidt, L. J., Kidd, E., Raclaw, K. A., Regan, K. M., & Tindall, D. J. (2010) · The Prostate · doi:10.1002/pros.21130 · Cited by 23
Self-citationIdentification of Ube2b as a Novel Target of Androgen Receptor in Mouse Sertoli Cells1
Mou, L., Zhang, Q., Wang, Y., Zhang, Q., Sun, L., Li, C., Huang, W., Yuan, Y., Duan, Y., Diao, R., et al. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.112.103648 · Cited by 23
Transcription Factors Involved in Prostate Gland Adaptation to Androgen Deprivation
Rosa‐Ribeiro, R., Nishan, U., Vidal, R. O., Barbosa, G. O., Reis, L. O., Cesar, C. L., & Carvalho, H. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097080 · Cited by 23
Role of Androgen and Estrogen Receptors for the Action of Dehydroepiandrosterone (DHEA)
Engdahl, C., Lagerquist, M. K., Stubelius, A., Andersson, A., Studer, E., Ohlsson, C., Westberg, L., Carlsten, H., & Forsblad‐d’Elia, H. (2014) · Endocrinology · doi:10.1210/en.2013-1561 · Cited by 23
Androgen receptor expression on circulating tumor cells in metastatic breast cancer
Fujii, T., Reuben, J. M., Huo, L., Fernández, J. R. E., Gong, Y., Krupa, R., Suraneni, M. V., Graf, R. P., Lee, J. S. H., Greene, S. B., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185231 · Cited by 22
Growth hormone affects gene expression and proliferation in human prostate cancer cells
Bidosee, M., Karry, R., Weiss‐Messer, E., & Barkey, R. J. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01064.x · Cited by 22
Zaman, N., Giannopoulos, P. N., Chowdhury, S. F., Bonneil, É., Thibault, P., Wang, E., Trifiro, M. A., & Paliouras, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113190 · Cited by 22
Clark, E. L., Fuller-Pace, F. V., Elliott, D. J., & Robson, C. N. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360546 · Cited by 22
Urbanucci, A., Marttila, S., Jänne, O. A., & Visakorpi, T. (2011) · The Prostate · doi:10.1002/pros.22473 · Cited by 22
Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer
He, H., Gu, X., Xu, W., Yang, D., Wang, X., & Su, Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.130 · Cited by 22
Copland, J. A., Sheffield-Moore, M., Koldzic-Zivanovic, N., Gentry, S., Lamprou, G., Tzortzatou-Stathopoulou, F., Zoumpourlis, V. C., Urban, R., & Vlahopoulos, S. A. (2009) · Bioessays · doi:10.1002/bies.200800138 · Cited by 28
Current state of castration-resistant prostate cancer.
Petrylak, D. P. (2013) · PubMed · Cited by 22
Antiandrogen withdrawal syndrome (AAWS) in the treatment of patients with prostate cancer
Leone, G., Tucci, M., Buttigliero, C., Zichi, C., Pignataro, D., Bironzo, P., Vignani, F., Scagliotti, G. V., & Maïo, M. D. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0355 · Cited by 22
Sobhani, N., Generali, D., D’Angelo, A., Aieta, M., & Roviello, G. (2018) · Investigational New Drugs · doi:10.1007/s10637-018-0653-2 · Cited by 22
The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Kırlangıç, O. F., Yilmaz‐Oral, D., Kaya‐Sezginer, E., Toktanis, G., Tezgelen, A. S., Sen, E., Khanam, A., Öztekin, Ç. V., & Gür, S. (2020) · Sexual Medicine · doi:10.1016/j.esxm.2020.02.006 · Cited by 23
Coordinated AR and microRNA regulation in prostate cancer
Eringyte, I., Losada, J. N. Z., Powell, S. M., Bevan, C. L., & Fletcher, C. E. (2020) · Asian journal of urology · doi:10.1016/j.ajur.2020.06.003 · Cited by 24
Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL
Chen, S., Chen, K., Zhang, Q., Cheng, H., & Zhou, R. (2013) · Biochemical Journal · doi:10.1042/bj20121711 · Cited by 22
The landscape of N6-methyladenosine in localized primary prostate cancer
Xu, X., Zhu, H. H., Hugh-White, R., Livingstone, J. M., Eng, S. E., Zeltser, N., Wang, Y., Pajdzik, K., Chen, S., Houlahan, K. E., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02128-y · Cited by 22
Yan, H., Shen, X., Jiang, J., Zhang, L., Yuan, Z., Wu, Y., Liu, Q., & Liu, Y. (2021) · Endocrinology · doi:10.1210/endocr/bqab068 · Cited by 21
Dahiya, U. R., & Heemers, H. V. (2022) · Cells · doi:10.3390/cells11060936 · Cited by 20
Self-citationNon-canonical androgen signaling pathways and implications in prostate cancer
Dahiya, V., & Bagchi, G. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119357 · Cited by 23
Yan, J., Xie, B., Capodice, J. L., & Katz, A. E. (2011) · The Prostate · doi:10.1002/pros.21426 · Cited by 21
Wu, F., Peacock, S. O., Rao, S., Lemmon, S. K., & Burnstein, K. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.390963 · Cited by 21
Imperlini, E., Mancini, A., Spaziani, S., Martone, D., Alfieri, A., Gemei, M., Vecchio, L. D., Buono, P., & Orrù, S. (2010) · PROTEOMICS · doi:10.1002/pmic.201000079 · Cited by 21
Androgen suppresses testicular cancer cell growthin vitroandin vivo
Nakagawa, H., Ueda, T., Ito, S., Shiraishi, T., Taniguchi, H., Kayukawa, N., Nakanishi, H., Ushijima, S., Kanazawa, M., Nakamura, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9109 · Cited by 21
Armstrong, C. M., & Gao, A. C. (2016) · Asian journal of urology · doi:10.1016/j.ajur.2016.08.001 · Cited by 21
Han, W., Xie, W., Zhang, Y., Zhang, F., Zhang, H., Han, Y., Yuan, Z., & Weng, Q. (2017) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2017.09.015 · Cited by 21
Androgen Deprivation Therapy for Prostate Cancer
Pagliarulo, V. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-99286-0_1 · Cited by 21
Venkadakrishnan, V. B., DePriest, A. D., Kumari, S., Senapati, D., Ben‐Salem, S., Su, Y., Mudduluru, G., Hu, Q., Cortes, E., POP, E. A., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0732-7 · Cited by 20
Self-citationRokhlin, O. W., Guseva, N. V., Taghiyev, A. F., Glover, R. A., & Cohen, M. B. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.3.10747 · Cited by 21
Nejishima, H., Yamamoto, N., Suzuki, M., Furuya, K., Nagata, N., & Yamada, S. (2012) · The Prostate · doi:10.1002/pros.22511 · Cited by 21
Rationale for the development of alternative forms of androgen deprivation therapy
Kumari, S., Senapati, D., & Heemers, H. V. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0121 · Cited by 21
Self-citationKumar, S., & Tyagi, R. K. (2012) · FEBS Journal · doi:10.1111/febs.12046 · Cited by 19
Chromatin reprogramming as an adaptation mechanism in advanced prostate cancer
Braadland, P. R., & Urbanucci, A. (2019) · Endocrine Related Cancer · doi:10.1530/erc-18-0579 · Cited by 21
The Genetics of Castration-Resistant Prostate Cancer: What Can the Germline Tell Us?
Sharifi, N., Dahut, W. L., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0453 · Cited by 20
Hay, C. W., Hunter, I., MacKenzie, A., & McEwan, I. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139990 · Cited by 20
Analysis of Androgen Receptor SUMOylation
Rytinki, M. M., Kaikkonen, S., Sutinen, P., & Palvimo, J. J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-243-4_12 · Cited by 20
Hsiao, J. J., Smits, M. M., Ng, B. H., Lee, J., & Wright, M. E. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.732313 · Cited by 20
Mao, Y., Yang, G., Li, Y., Liang, G., Xu, W., & Hu, M. (2022) · Cancers · doi:10.3390/cancers14153744 · Cited by 21
Wafa, L. A., Cheng, H., Plaa, N., Ghaidi, F., Fukumoto, T., Fazli, L., Gleave, M. E., Cox, M., & Rennie, P. S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26287 · Cited by 20
Fialova, B., Luzna, P., Gurský, J., Langová, K., Kolář, Z., & Trtková, K. S. (2016) · Oncology Reports · doi:10.3892/or.2016.5000 · Cited by 19
Akimoto, C., Ueda, T., Inoue, K., Yamaoka, I., Sakari, M., Obara, W., Fujioka, T., Nagahara, A., Nonomura, N., Tsutsumi, S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010307107 · Cited by 19
RetractedBTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity
Hu, X., Meng, Q., Xu, J., Jiao, Y., Ge, C., Jacob, A., Wang, P., Rosen, E. M., & Fan, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.064 · Cited by 19
Udayakumar, T. S., Stoyanova, R. S., Shareef, M. M., Mu, Z., Philip, S., Burnstein, K. L., & Pollack, A. S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0332 · Cited by 20
Krawczyk, N., Neubacher, M., Meier-Stiegen, F., Neubauer, H. J., Niederacher, D., Ruckhäberle, E., Mohrmann, S., Hoffmann, J., Kaleta, T., Banys-Paluchowski, M. J., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-6323-8 · Cited by 19
Identification of Hsf1 as a novel androgen receptor‐regulated gene in mouse Sertoli cells
Yang, L., Wang, Y., Zhang, Q., Lai, Y., Li, C., Zhang, Q., Huang, W., Duan, Y., Jiang, Z., Li, X., et al. (2014) · Molecular Reproduction and Development · doi:10.1002/mrd.22318 · Cited by 19
Buchanan, G., Need, E. F., Barrett, J. M., Bianco‐Miotto, T., Thompson, V. C., Butler, L. M., Marshall, V. R., Tilley, W. D., & Coetzee, G. A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.05.023 · Cited by 19
Kumar, S., Jaiswal, B., Kumar, S., Negi, S., & Tyagi, R. K. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.06.009 · Cited by 19
Emerging cell cycle inhibitors for treating metastatic castration-resistant prostate cancer
Batra, A., & Winquist, E. (2018) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2018.1547707 · Cited by 19
Long non‑coding RNAs in prostate tumorigenesis and therapy (Review)
Jiang, G., SU, Z., Liang, X., Huang, Y., Lan, Z., & Jiang, X. (2020) · Molecular and Clinical Oncology · doi:10.3892/mco.2020.2146 · Cited by 19
Expression of AIB1 protein as a prognostic factor in breast cancer
Lee, K., Lee, A., Song, B. J., & Kang, C. S. (2011) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-9-139 · Cited by 19
Wang, Z., Kim, J., Teng, Y., Ding, H.-F., Zhang, J., Hai, T., Cowell, J. K., & Yan, C. (2015) · Oncogene · doi:10.1038/onc.2015.417 · Cited by 19
Whirledge, S., & Cidlowski, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00005-6 · Cited by 19
de Nóbrega, M., Cilião, H. L., de Souza, M. F., de Souza, M. R., Serpeloni, J. M., Fuganti, P. E., & Cólus, I. M. D. S. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0329 · Cited by 18
Guilherme, J. P. L. F., Шихова, Ю. В., Дондуковская, Р. Р., Топанова, А. А., Semenova, E. A., Astratenkova, I. V., & Ahmetov, I. I. (2021) · Annals of Human Biology · doi:10.1080/03014460.2021.1919204 · Cited by 18
Nuclear hormone receptors in demyelinating diseases
Zorrilla-Veloz, R. I., McKenzie, T., Palacios, B. E., & HU, J. L. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13171 · Cited by 19
AR-regulated ZIC5 contributes to the aggressiveness of prostate cancer
Tan, Y.-F., Zhang, Y., Ge, S., Zhong, F., Sun, C., & Xia, G. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01181-4 · Cited by 18
Chang, C., Chen, J., Chen, T.-H., & Chen, R. (2022) · Molecules · doi:10.3390/molecules27196666 · Cited by 18
Targets to treat androgen excess in polycystic ovary syndrome
Luque‐Ramírez, M., & Escobar-Morreale, H. F. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075511 · Cited by 18
Batth, I. S., Yun, H., Hussain, S. S., Meng, P., Osmulski, P. A., Huang, T. H. ‐., Bedolla, R. G., Profit, A. L., Reddick, R. L., & Kumar, A. P. (2016) · Oncotarget · doi:10.18632/oncotarget.7287 · Cited by 18
Metadata
- Authors
- Heemers, H. V., & Tindall, D. J.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Tindall, Donald J.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2007-10-16
- Volume
- 28
- Issue
- 7
- Pages
- 778-808
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2164092182
- Cited by
- 753
- References
- 375
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 30 · 2023: 29 · 2022: 40 · 2021: 48 · 2020: 26 · 2019: 37 · 2018: 37 · 2017: 38 · 2016: 54 · 2015: 49 · 2014: 42 · 2013: 70 · 2012: 52
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA121277, CA125747, R01CA125747, CA 91956, CA121277, P50CA091956, CA 15083, P30CA015083)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK065236, DK65236)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- androgen receptor, coregulators, transcriptional coactivator, corepressors, transcriptional complex, androgen signaling, male reproductive development, prostate cancer, androgen insensitivity syndrome
- MeSH terms
- Androgens, Gene Expression Regulation, Humans, Male, Receptors, Androgen, Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review